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Abstract Objective: pCO2 gradients
are used for the assessment of
splanchnic regional and local mucos-
al blood flow changes in experimen-
tal and clinical research. pCO2 gradi-
ents may not parallel blood flow
changes because of concomitant
changes in metabolism, hemoglobin,
temperature, and the Haldane effect.
Design and setting: A randomized,
controlled animal experiment in a
university experimental research lab-
oratory. Interventions: An extracor-
poreal shunt with reservoir and roller
pump was inserted between the
proximal and the distal abdominal
aorta in 16 pigs. In animals random-
ized to the low-flow group (n=8)
splanchnic perfusion was reduced by
running the roller pump. At baseline
and after 45 min of stable shunt flow
superior mesenteric artery, celiac
trunk, spleen artery, and portal vein
blood flows and regional venous-ar-
terial and jejunal and gastric mucos-
al-arterial pCO2 gradients were 
measured, and the respective 
regional O2 consumption rates (VO2) calculated. Measurements 
and results: In the low-flow group
all regional blood flows and the as-
sociated VO2 decreased to roughly
50% of baseline values, and hemo-
globin decreased from 7.3 (4.4–9.6)
g/dl to 5.7 (4.1–8.9) g/dl. Decreasing
regional blood flows were consis-
tently associated with increasing re-
gional and mucosal pCO2 gradients.
Conclusions: During isolated reduc-
tion in abdominal aortic blood flow
there is no preferential distribution to
any splanchnic vascular bed and
changes in regional pCO2 gradients
reflect consistently the associated
blood blow changes.
Keywords Low flow · Metabolism ·
pCO2 gradients · Regional blood
flow · Splanchnic perfusion
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Changes in regional blood flow and pCO2
gradients during isolated abdominal aortic
blood flow reduction
Introduction
The gastrointestinal tract seems to be a major contributor
to the pathogenesis of the systemic inflammatory re-
sponse syndrome, sepsis, and multiple organ failure in
critical illness [1, 2, 3, 4]. The concept of an overpropor-
tional decrease in the perfusion of visceral organs in
low-flow states to maintain central blood volume and
cardiac output has been developed in earlier studies [5,
6, 7, 8, 9]. Hemodynamic variables and global parame-
ters of tissue perfusion such as acid-base status, blood
lactate concentration, and mixed venous oxygen satura-
tion poorly reflect regional tissue perfusion [10, 11, 12,
13]. Monitoring of CO2 tension in the arterial and ve-
nous blood has been suggested for detection of poor re-
gional and local tissue perfusion and oxygenation [14,
15, 16, 17]. Under clinical conditions the direct determi-
nation of venous-arterial pCO2 gradients in the splanch-
nic vascular beds is not feasible. Intramucosal pCO2 can
be measured indirectly within the lumen of the gastroin-
testinal tract by gastrointestinal tonometry [18]. Howev-
er, the clinical utility of gastrointestinal tonometry re-
mains controversial [19, 20, 21], and studies that evalu-
ate the correlation between the intramucosal pH (calcu-
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lated from intramucosal pCO2 using the modified Hen-
derson-Hasselbalch equation [22, 23]) and splanchnic
blood flow demonstrate inconsistencies [24].
The cellular CO2 level depends on the balance be-
tween (a) CO2 production via both aerobic and anaerobic
metabolism and (b) CO2 removal by blood flow from the
particular tissue bed and by alveolar ventilation from the
systemic circulation [25]. The regional CO2 production
is expressed as the product of the respective blood flow
and the venous-arterial CO2 content difference. The ra-
tionale behind the use of mucosal-arterial (venous-arteri-
al) pCO2 gradients as a measure of the adequacy of mu-
cosal (regional) blood flow is the almost linear relation-
ship between the blood carbon dioxide content and the
corresponding pCO2 under stable conditions. However,
there are potential confounding factors such as concomi-
tant changes in hemoglobin, pH, temperature, and the
Haldane effect: increasing oxygen saturation increases
the pCO2 for any given carbon dioxide content and vice
versa [26]. Furthermore, changes in the local or regional
CO2 content can occur as a result of phenomena entirely
related to metabolism. Hence pCO2 gradients may not
parallel blood flow changes.
Due to the complex anatomy and physiology of the
splanchnic circulation and the limited access to these
vascular beds in patients the interaction between changes
in metabolism and blood flow and their effect on the
measured regional and mucosal pCO2 gradients cannot
be tested in the clinical setting. We therefore developed
an experimental porcine model to selectively reduce the
abdominal blood flow with limited systemic side effects.
The aims of this study were the following: (a) to assess
the regional blood flow distribution within the splanch-
nic circulation, (b) to compare regional perfusion, oxy-
gen consumption, and pCO2 gradients during isolated re-
duction in visceral blood flow, and (c) to assess whether
confounding factors such as changes in temperature, he-
moglobin, and the Haldane effect affect the relationship
between regional venous-arterial pCO2 gradients and
blood flow in a low visceral perfusion state.
Materials and methods
Anesthesia and monitoring
This study was performed according to the National Institutes of
Health guidelines for the use of experimental animals, and the pro-
tocol was approved by the Animal Care Committee of the Canton
of Berne. Sixteen pigs of both genders (weight range 37–43 kg)
were deprived of food but not water 24 h before the experiment.
They were premedicated intramuscularly with 0.05 mg/kg atro-
pine, 4 mg/kg xylacine, and 15 mg/kg ketamine followed by can-
nulation of an ear vein and intravenous administration of
5–10 mg/kg thiopental sodium for endotracheal intubation. As de-
scribed previously, anesthesia was maintained with 5 mg/kg thio-
pental sodium and 30 µg/kg fentanyl per hour during the operation
[27, 28]. After completion of surgery the hourly fentanyl adminis-
tration was reduced to 5 µg/kg and muscle relaxation with 1 mg/kg
pancuronium per hour was started. The animals were mechanical-
ly ventilated with a volume-controlled ventilator (Servo 900C,
Siemens, Solna, Sweden) with 5 cmH2O end-expiratory pressure.
Fractional inspired oxygen concentration was adjusted to keep
paO2 levels between 100 and 150 mmHg. Tidal volume was kept
at 10 ml/kg and the minute ventilation was adjusted to maintain
paCO2 levels between 34 and 41 mmHg. A large-bore gastric tube
was introduced into the stomach via the mouth. A right-sided ca-
rotid artery catheter, a pulmonary artery catheter (via the right
submandibular vein), a catheter for later placement in a hepatic
vein (via the right internal jugular vein,) and a right-sided femoral
artery catheter were inserted. During surgery and the experiment
the animals received per hour 10 ml/kg Ringer’s lactate, 10 ml/kg
gelatin solution (Physiogel), and 5 ml/kg 5% glucose. Additional
fluid was administered if necessary to keep the pulmonary artery
occluded pressure between 5 and 8 mmHg. The goal was to keep
the body temperature of the animals at 39°±0.5°C by using an op-
erating table heater, warmed fluids, and a blanket.
Animal preparation
The abdominal cavity was exposed by a midline abdominal inci-
sion. A drainage catheter was inserted into the urinary bladder.
The superior mesenteric, splenic, hepatic, and femoral arteries, the
celiac trunk, and the portal vein were exposed, and ultrasound
transit time flow probes (Transonic Systems, Ithaca, N.Y., USA)
were placed around the vessels. Two fluid-filled catheters were in-
serted proximally and distally into a mesenteric vein. The tip of
the first catheter was placed into the portal vein, while the tip of
the second catheter remained in the mesenteric vein. A third cathe-
ter was inserted into the splenic vein. The abdominal aorta was ex-
posed through the left retroperitoneal space, and an ultrasound
flow probe was placed around the aorta proximally to the origin of
the celiac trunk. A 20-F curved venous cardiopulmonary bypass
cannula (Medtronic Cardiopulmonary, Anaheim, Calif., USA) was
inserted into the abdominal aorta proximal to the aortic flow
probe, and a second 20-F cannula was inserted into the distal aorta
with the tip located proximal to the aortic bifurcation. The cannu-
las were connected to each other using silicon cardiopulmonary
bypass tubes, a cardiotomy reservoir (Jostra, Irvine, Calif., USA)
and a precision blood roller pump (Cobe, Denver, Colo., USA). A
vascular occluder was placed around the aorta proximal to the dis-
tal cannula, and an aortic ultrasound flow probe was placed distal
to the cannula (a schematic illustration of the shunt system is
shown in Fig. 1). The pig received boli of 1000–2500 IU heparin
to keep the activated clotting time at a level of 400 s minimum.
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Fig. 1 Shunt system
The measurements were performed using high-range activated
clotting time cartridges (Medtronic, Minneapolis, Minn., USA)
and an automatized activated clotting time analyzer (Medtronic
HemoTec, Parker, Colo., USA). The catheter within the right in-
ternal jugular vein was further inserted and the location of the tip
within a hepatic vein was confirmed by direct manual palpation.
Thereafter the catheter was withdrawn 0.5–1 cm from the wedged
position to allow blood sampling. A jejunal and a gastric air to-
nometry catheter (Tonometrics, TRIP NGS Catheter, Datex-Oh-
meda, Helsinki, Finland) were inserted through an incision in the
jejunal wall and orally, respectively, and connected to a Tonocap
system (Datex-Ohmeda), after which the incision in the intestinal
wall was closed with sutures. When all surgical procedures were
completed, the abdominal wall was reapproximated gently, and
towels were placed on the surface to minimize heat loss.
Experimental protocol
After preparation 180 min was allowed for hemodynamic stabili-
zation before baseline measurements were made and samples were
taken. The animals were randomized into two groups: a control
group (n=8) and a low-flow group (n=8). In the low-flow group
the distal abdominal aorta was occluded to prevent backflow from
the distal cannula, and the abdominal aortic flow was reduced to a
target total hepatosplanchnic blood flow (=celiac trunk + superior
mesenteric arterial blood flow) of 50% of the baseline value by
running the roller pump. Once the target abdominal aortic blood
flow was reached, the shunt blood flow was kept constant for
45 min. In four randomly allocated animals in the control group
(“control/low shunt flow”), the shunt was activated with a low
shunt flow of 250 ml/min to control for potential effects of the
shunt per se. In the other four animals of the control group the
shunt remained closed. At the end of the experiment the animals
were killed by an overdose of intravenous potassium. Afterwards
the correct position of the hepatic vein catheter was confirmed by
anatomical dissection of the liver.
The protocol was carried out in 18 animals. Two animals were
excluded post hoc because of discrepancies between size of aorta
and aortic cannula with subsequent hypoperfusion of the legs in
one animal and bleeding with severe anemia (baseline hemoglobin
level less than 4 g/100 ml) in another animal. Measurements after
45 min are labeled as “second measurement”. There were no dif-
ferences between groups in systemic hemodynamics and regional
blood flow measurements at baseline. In one animal in the low-
flow group the spleen flow probe was not properly working, and
in one animal in the low-flow group and two in the control group
it was not possible to obtain blood samples from the mesenteric
vein. The corresponding results are therefore missing in the re-
spective animals.
Hemodynamic monitoring
Aortic, carotid, pulmonary, and femoral arterial blood pressures,
pulmonary artery occluded pressure, and central venous pressure
were recorded with quartz pressure transducers and displayed con-
tinuously on a multimodular monitor and recorder (S/5 Critical
Care Monitor, Datex-Ohmeda). All pressure transducers were si-
multaneously zeroed to the level of the heart. Cardiac output was
measured by a thermodilution technique (mean value of four mea-
surements). Central venous blood temperature was recorded from
the thermistor in the pulmonary artery catheter. Heart rate was
measured by electrocardiography, which was also continuously
monitored.
Blood flow measurements
Abdominal aortic and regional blood flows were measured by ul-
trasound transit time flow probes (Transonic Systems). The transit
time ultrasound volume flowmeter has been demonstrated to pro-
vide adequate measures of arterial and venous flows in experimen-
tal animals if carefully positioned and aligned with respect to the
vessel [29, 30]. The perivascular ultrasound flow probes were cali-
brated in vitro and the signals were visualized and recorded con-
tinuously (Flowmeters T108 and T208, Transonic Systems).
Blood gas and lactate measurements
Blood samples for the measurement of hemoglobin, blood gas
analysis, and lactate were taken at baseline and after 45 min of sta-
ble shunt flow from carotid and pulmonary arteries and from por-
tal, hepatic, mesenteric, and splenic veins and were analyzed im-
mediately after withdrawal. Hemoglobin concentrations and oxy-
gen saturations were measured by an analyzer designed for por-
cine blood (OSM 3, Radiometer, Copenhagen, Denmark), and lac-
tate and blood gases were analyzed at 37°C in a blood gas, electro-
lyte and lactate analyzer (ABL 520, Radiometer).
Calculations
Systemic and regional venous-arterial carbon dioxide content dif-
ferences were calculated using an iterative procedure as proposed
by Giovannini and colleagues [31] (see Appendix). Since the ac-
curacy of this method may be reduced if the metabolic acid-base
status in venous and arterial blood largely differs [31], calculations
at 45 min were performed only in control animals. The Haldane
effect and changes in blood pCO2 mediated by changes in hemo-
globin-O2 saturation and O2-linked CO2 binding was calculated as[32]:
(v-a)pCO2HE=0.460 [(a-v)HbO2]0.999e0.015 (pvCO2)−0.852 (Hct) Re-
gional carbon dioxide production was calculated as the product of
venous-arterial carbon dioxide content difference and regional
blood flow. Regional oxygen consumption was calculated as the
product of regional blood flow and arterial-venous oxygen content
difference.
Statistics
Statistical analysis was performed with the SPSS software (ver-
sion 10.0, SPSS, Chicago, Ill., USA). Because the number of ani-
mals per group was small, nonparametric tests were used. Visual-
ization of blood flow and metabolic changes within controls and
“control/low shunt flow” animals demonstrated no differences.
These groups were therefore combined for the statistical analysis
(“control group”). Groups at baseline were compared using the
Mann-Whitney U test; changes over time in each group were sepa-
rately assessed by the Wilcoxon test. For the relative flow changes
in the shunt group we used Friedman’s test. Statistical significance
was set at p<0.05. All results are presented as median (range) un-
less stated otherwise.
Results
Systemic hemodynamics and central temperature are
shown in Table 1. At baseline there were no difference
between the two groups. At the second measurement
heart rate and cardiac output were increased in the con-
trol group while mean arterial pressure did not change in
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Table 1 Hemodynamics, temperature, arterial blood gas measurements, and hemoglobin
Baseline Second measurement p
Median Range Median Range Baseline Intervention
Heart rate (beats/min) 0.44
Low flow 116 72–187 147 75–167 0.10
Control 103 73–156 129 81–178 0.03
Systemic mean arterial pressure (mmHg) 0.33
Low flow 86 76–105 74 67–112 0.33
Control 94 66–118 90 75–114 0.89
Pulmonary artery occluded pressure (mmHg) 0.16
Low flow 6 4–9 6 2–7 0.02
Control 7 5–9 6 5–9 0.07
Cardiac output (ml kg−1 min−1) 0.15
Low flow 99 74–169 110 83–190 0.35
Control 118 94–160 115 107–210 0.07
Central temperature (°C) 0.65
Low flow 39.8 37.3–41.3 38.7 34.4–39.9 0.01
Control 39.9 38.2–41.5 39.6 38.5–41.4 0.09
pH 0.33
Low flow 7.41 7.34–7.47 7.37 7.30–7.43 0.09
Control 7.42 7.40–7.45 7.43 7.38–7.46 0.40
pCO2 (mmHg) 0.96
Low flow 40 35–48 38 34–44 0.02
Control 41 37–46 40 36–42 0.07
SaO2 (%) 0.96
Low flow 97 96–98 98 97–99 0.03
Control 98 95–98 98 95–98 0.12
Hemoglobin (g/dl) 0.65
Low flow 7.3 4.4–9.6 5.7 4.1–8.9 0.02
Control 6.1 5.3–8.8 5.7 4.7–9.0 0.12
either group. In the low-flow group wedge pressure was
decreased. Blood gas measurements and hemoglobin
values are also shown in Table 1. Arterial pCO2 and he-
moglobin were decreased in the low-flow group, but re-
mained unchanged in controls. Aortic and regional blood
flows are shown in Table 2. Aortic and regional blood
flows did not differ at baseline, and changes in controls
were not significant. In the low-flow group abdominal
aortic and all regional blood flows were decreased by
50%–80%. The relative flow changes did not differ in
the individual vascular beds (p=0.45). There were no dif-
ferences in blood lactate concentrations at baseline be-
tween animals in the two groups (Table 3). Lactate con-
centrations increased in the venous effluents of all vascu-
lar beds in animals from the low-flow group.
The regional venous-arterial pCO2-gradients did not
differ between groups at baseline (Table 4). In the low-
flow group the splenic, mesenteric, and portal venous-
arterial pCO2 gradient was increased. In the control
group overall venous-arterial CO2 content differences
remained unchanged. In general, small changes in CO2
content differences corresponded well with the respec-
tive changes in pCO2 differences (Fig. 2). Gastric andjejunal tonometric values, although highly variable in
both groups, were increased in low flow animals (Ta-
ble 4). Changes in blood pCO2 mediated by changes in
Hb-O2 saturation and O2-linked CO2 binding provided
a mean regional (v-a)pCO2HE value of 4 mmHg (all
animals and conditions). During low flow, values of up
to 10 mmHg were obtained. The relative contribution to
the measured regional pCO2 gradients was 23%–48%,
depending on the respective region. Results for regional
oxygen consumption (VO2) and oxygen extraction rates
are shown in Table 5. Hepatic oxygen consumption was
Table 3 Systemic arterial and regional venous lactate
Baseline Second measurement p
Median Range Median Range Baseline Intervention
Arterial (mmol/l) 0.20
Low flow 0.9 0.5–1.5 3.2 1.2–4.8 0.01
Control 0.7 0.8–2.1 0.8 0.5–1.4 0.50
Mesenteric vein (mmol/l) 0.30
Low flow (n=7) 1.2 0.7–1.6 5.2 1.5–6.0 0.03
Control (n=6) 0.9 0.6–2.1 1.0 0.6–1.5 1.00
Hepatic vein (mmol/l) 0.23
Low flow 0.7 0.3–1.1 3.1 1.1–5.5 0.01
Control 0.5 0.2–1.5 0.6 0.2–1.0 0.50
Splenic vein (mmol/l) 0.10
Low flow (n=7) 1.1 0.6–1.7 3.1 1.4–5.6 0.01
Control (n=6) 0.7 0.6–2.2 0.9 0.7–1.7 0.34
Portal vein (mmol/l) 0.13
Low flow 1.1 0.6–1.6 3.6 1.3–5.3 0.01
Control 0.8 0.6–1.8 0.9 0.5–1.5 0.43
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Table 2 Aortic and regional blood flows
Baseline Second measurement p
Median Range Median Range Baseline Intervention
Aortic flow (ml kg−1 min−1) 1.00
Low flow 71 30–103 16 2–38 0.01
Control 70 61–88 72 37–91 0.89
Superior mesenteric artery flow (ml kg−1 min−1) 0.06
Low flow 18 12–31 11 5–23 0.01
Control 27 20–33 28 19–31 0.33
Celiac trunk artery flow (ml kg−1 min−1) 0.72
Low flow 18 5–23 10 2–16 0.01
Control 16 11–22 19 14–21 0.07
Hepatic artery flow (ml kg−1 min−1) 0.57
Low flow 8 4–18 2 1–14 0.01
Control 10 5–12 10 6–15 0.16
Spleen artery flow (ml kg−1 min−1) 0.69
Low flow (n=7) 1.5 1.2–3.0 0.8 0.3–1.8 0.02
Control (n=7) 1.9 0.5–6.2 1.8 0.5–5.5 0.89
Portal vein flow (ml kg−1 min−1) 0.57
Low flow 30 19–44 18 10–31 0.01
Control 33 25–41 34 20–40 0.78
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Table 4 Regional and mucosal pCO2 gradients and tonometry data
Baseline Second measurement p
Median Range Median Range Baseline Intervention
Mesenteric pCO2 gradient (mmHg) 0.18
Low flow (n=7) 15 6–19 28 8–54 0.04
Control (n=6) 11 8–16 11 5–17 0.89
Hepatic pCO2 gradient (mmHg) 0.65
Low flow 11 6–18 15 7–44 0.11
Control 10 8–13 10 7–12 0.64
Splenic pCO2 gradient (mmHg) 0.61
Low flow 7 5–12 15 8–31 0.01
Control 8 3–14 6 1–12 0.74
Portal pCO2 gradient (mmHg) 0.23
Low flow 13 7–19 22 10–39 0.03
Control 10 8–13 9 7–15 0.89
Gastric tonometric-arterial pCO2 gradient (mmHg) 0.96
Low flow 33 6–84 45 6–82 0.05
Control 36 14–79 39 14–85 0.31
Jejunal tonometric-arterial pCO2 gradient (mmHg) 0.52
Low flow 9 1–24 44 10–101 0.04
Control 7 1–10 6 2–10 1.00
Table 5 Regional oxygen consumption and oxygen extraction rates
Baseline Second measurement p
Median Range Median Range Baseline Intervention
Mesenteric VO2 (ml kg−1 min−1) 0.10
Low flow (n=7) 0.8 0.4–1.3 0.5 0.3–1.2 0.02
Control (n=6) 1.1 0.8–2.3 1.1 0.7–2.0 0.31
Hepatic VO2 (ml kg−1 min−1) 0.04
Low flow 0.8 0.4–1.6 0.4 0.2–1.8 0.26
Control 1.2 0.8–2.5 1.4 0.7–2.7 0.89
Splenic VO2 (ml kg−1 min−1) 0.38
Low flow (n=7) 0.06 0.02–0.12 0.04 0.01–0.07 0.04
Control (n=6) 0.03 0.02–0.08 0.03 0.02–0.09 0.50
Portal VO2 (ml kg−1 min−1) 0.38
Low flow 1.4 0.7–2.1 0.8 0.5–1.6 0.01
Control 1.2 0.8–1.6 1.0 0.4–1.4 0.12
Mesenteric oxygen extraction (%) 0.14
Low flow (n=7) 49 20–75 77 30–83 0.09
Control (n=6) 41 34–44 40 27–72 0.75
Hepatic oxygen extraction (%) 0.13
Low flow 38 19–68 59 21–90 0.05
Control 51 32–68 51 41–62 0.67
Splenic oxygen extraction (%) 0.54
Low flow (n=7) 37 13–63 76 26–92 0.01
Control (n=6) 38 11–44 27 10–64 1.00
Portal oxygen extraction (%) 0.13
Low flow 53 24–61 70 40–81 0.07
Control 42 23–51 39 13–56 0.40
somewhat higher in control animals at baseline. Re-
gional VO2 remained stable in control animals. In the
low-flow group mesenteric, splenic and portal oxygen
consumption was decreased, while only the increase in
hepatic and splenic oxygen extraction rate reached sta-
tistical significance.
Discussion
The main findings were as follows: (a) In the low-flow
group all regional flows decreased proportionally, no
vascular bed was preferentially perfused, and the perfu-
sion was not preferentially reduced to any vascular bed.
(b) Low abdominal blood flow was associated with a
substantial reduction in O2 consumption in several
splanchnic tissues. (c) In most instances small changes in
pCO2 gradients reflected the respective changes in CO2
content differences. (d) Despite major changes in oxygen
extraction, hemoglobin, and temperature the pCO2 gradi-
ents reflected changes in corresponding regional blood
flows in most of the cases (Fig. 3).
This study describes a new model for the assessment
of hemodynamic and metabolic effects of low splanchnic
blood flow. The model excludes to a great extent effects
of hemodynamic and metabolic changes in other vascu-
lar beds. The slight increase in cardiac output and heart
rate in the control group may reflect a systemic inflam-
matory reaction to surgery and indwelling catheters. The
lack of such a circulatory response in the low-flow group
may be explained by the slight reduction in left ventricu-
lar filling, as suggested by a reduction in pulmonary cap-
illary occlusion pressures in these animals. Both a reduc-
tion in systemic vascular resistance due to hemodilution
and the resulting reduction in blood viscosity as well as
potential mechanic effects of the running roller pump
may contribute [33, 34]. Another effect of the extracor-
poreal circulation was a reduction in temperature [35,
36, 37], which we were not able to prevent completely
by using warmed fluids and heating blankets. In future
experiments an in-line blood heater can be integrated in
the extracorporeal shunt system to prevent this problem.
Earlier studies have demonstrated an overproportional
decrease in the perfusion of visceral organs in experi-
mental circulatory shock [5, 6, 7, 8, 9]. It has been sug-
gested that contraction of the splanchnic, and specifical-
ly the splenic vascular bed, helps to maintain central
blood volume and cardiac output in hypovolemic states,
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Fig. 2 Splenic, mesenteric, hepatic, and portal venous-arterial
pCO2 gradient and venous-arterial pCO2 content difference
for instance, during fluid removal associated with hemo-
dialysis [38]. In the present study all regional blood
flows decreased in parallel by roughly 50% (Table 2);
the more marked reduction in abdominal aortic flow may
be explained by measuring errors due to turbulent blood
flow. It is important to realize that in the experiments by
Bailey and Bulkley and colleagues [7, 8, 9] low systemic
blood flow was achieved by a combination of hemor-
rhage and cardiac tamponade. The authors combined
hemorrhage and cardiac tamponade because they real-
ized that prior hemorrhage sensitized the animals to sub-
sequent tamponade. In our experiment hypovolemia was
prevented, which could explain the discrepancies be-
tween our findings and those of their experiments.
The reduction in regional blood flows was associated
with marked decreases in regional O2 consumption and
increases in oxygen extraction rates in individual ani-
mals, especially in the low-flow group (Table 5). While
some of the changes may be due to mathematical cou-
pling associated with the use of shared variables in the
calculations [39], and others may be explained by associ-
ated falls in temperature, we believe that the reduction in
regional metabolism in animals in the low-flow group is
due to a transition to flow-dependent metabolism [40].
The rising blood lactate concentrations from the different
splanchnic tissues (Table 3) support this assumption. Our
results and those of others [41] also demonstrate that the
flow/metabolism relationship is not uniform in different
splanchnic vascular regions. On the other hand, in this
experimental setting gastric and jejunal pCO2 gradients
increased similarly, corresponding to a similar decrease
in celiac trunk and superior mesenteric arterial blood
flow. Accordingly, as far as our experimental design is
comparable to a situation of low systemic blood flow in
humans, it can be postulated that gastric tonometry de-
tects substantial changes in mesenteric perfusion.
The rationale behind the use of pCO2 gradients as an
estimate of related blood flow changes is the almost lin-
ear relationship between blood carbon dioxide content
and pCO2, assuming unchanged oxygen saturation, he-
moglobin, and pH. Although our results demonstrate such
a linear relationship in the group as a whole, in individual
animals there was a dissociation between changes in
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Fig. 3 Mesenteric venous-arterial pCO2 gradient and superior me-
senteric artery flow, splenic venous-arterial pCO2 gradient and
splenic artery flow, hepatic venous-arterial pCO2 gradient and to-
tal hepatic blood flow, and portal venous-arterial pCO2 gradient
and portal venous flow
pCO2 gradients and the respective CO2 content differ-
ences (Fig. 2). Several methods exist to calculate regional
venous-arterial CO2 content differences [42, 43]. Unfor-
tunately their accuracy is limited in low flow states. The
method proposed by Giovannini et al. [31], for instance,
may not be applied in situations with massive release of
acid ions from anaerobic tissue metabolism into slowly
flowing venous blood in shock states because of the dis-
crepancy between CO2-binding properties of venous and
arterial blood. Therefore calculation of regional venous-
arterial CO2 content differences and CO2 production is
difficult. Major changes in (venous) oxygen saturation,
hemoglobin, and the venous-arterial pH difference oc-
curred in the present experiment, and such changes also
occur during surgery and intensive care in patients [26].
Among these effects the Haldane effect is quantitatively
the most important one. The Haldane effect describes the
phenomenon of a leftward shift of the CO2 dissociation
curve with decreasing oxygen saturation [44, 45]. The
Haldane effect plays an important role for the magnitude
of changes in pCO2 gradients for a given change in blood
flow as long as the oxygen extraction increases with de-
creasing blood flow, and hence the venous oxygen satura-
tion decreases. In our experiment the mean Haldane ef-
fect on venous-arterial pCO2 gradients was relatively
small (4 mmHg) although maximal values of 10 mmHg
were calculated. These values correspond to 23–48% of
the total pCO2 gradients. Despite this decreases in region-
al blood flows were almost always associated with corre-
sponding increases in the respective pCO2 gradients. Er-
rors in measurements of pCO2, hematocrit, and pH are
further explanations for the exceptional discrepancies be-
tween changes in CO2 content and pCO2 differences. The
present model produces regional ischemic hypoxia and
obviously lacks the ability to limit the increasing pCO2
gradients associated with major CO2 stagnation. In mod-
els in which the oxygen content is decreased in the pres-
ence of maintained blood flow (hypoxic hypoxia [46,
47]), the Haldane effect would become a principal pro-
cess in eliminating CO2.
Progressive anemia during the experiment is another
potential confounding factor. During isovolemic anemia
down to a hematocrit of 12%, CO2 transport is main-
tained mainly by an increased blood flow and an aug-
mented Haldane effect induced by the increased oxygen
extraction [48]. Arterial, venous, and mucosal pCO2 are
maintained [48, 49, 50]. In our experiment blood flow
decreased, and anemia progressed at the same time. We
believe that under these circumstances anaerobic metab-
olism develops earlier than reduction in blood flow with-
out anemia. The combined effect of low blood flow, an-
aerobic CO2 production, and an augmented Haldane ef-
fect on the course of the pCO2 gradients is difficult to
predict. Furthermore, changing body temperature in indi-
vidual animals may also have had an impact on the rela-
tionship between metabolism and blood flow.
We conclude that this new experimental model allows
a selective reduction in visceral blood flows to clinically
relevant levels while systemic perfusion is maintained.
The limitations are extensive surgery, difficulty in ob-
taining stable blood flow conditions and temperature,
and substantial hemodilution. Under the experimental
conditions, with prevention of hypovolemia, no preferen-
tial reduction or preservation of blood flows to the dif-
ferent visceral tissues occurred. In a setting of low blood
flow, even with concomitant metabolic changes, and pro-
gressive anemia pCO2 gradients can be used for the as-
sessment of blood flow changes.
Appendix: calculation of the venous-arterial 
CO2-content difference
Venous-arterial CO2-content difference was calculated
using the method developed by Giovannini et al. [31].
Briefly, the concentration of CO2 in arterial blood is de-
termined by the concentration of combined CO2 in plas-
ma (CaCO2p) and red blood cells (CaCO2r), dissolved
CO2 (CaCO2d ml/100 ml for all), and hematocrit. CaCO2
=CaCO2p. [1-Hct×(1−CaCO2r/CaCO2p)]+CaCO2d. CaCO2p
is calculated from the arterial pCO2 and pH on the basis
of the Henderson-Hasselbalch equation: CaCO2p=0.06868×(PaCO2)×{10[1.04214×(pHa)−6.41036]}. The value of
ra=CaCO2r/CaCO2p is obtained as a function of plasma
pH and arterial O2 saturation and by using a concentra-
tion fraction of water in plasma and red blood cells 
of 0.938 and 0.720, respectively: ra=2.5814−0.2640×
(pHa)−[0.2203−0.0376×(pHa)]×(1−SaO2). CaCO2d is fi-
nally calculated assuming a Bunsen coefficient for red
blood cells 0.00947 ml/100 ml mmHg lower than that of
plasma. CaCO2d=PaCO2×[0.06868−0.00947×(Hct)]. Any
increase in blood CO2 concentration related to the in-
crease in pCO2 and to the simultaneous decrease in
SaO2, which takes place when arterial blood becomes
venous, is calculated by considering these two compo-
nents separately and by using the mathematical model
developed and described in detail by Giovannini et al.
[31]. This model simulates the equilibration of whole
blood at increasing pCO2 to determine the virtual values
of combined CO2 concentration in plasma and of plasma
pH, resulting from the increase in pCO2 from arterial to
venous value at constant SaO2. In a further step the in-
crease in blood CO2 concentration that is related to the
decrease in O2 saturation from arterial to venous value at
constant pCO2 is then calculated. The total increment in
CO2 concentration from arterial to venous blood is final-
ly calculated from the sum of the two changes.
We compared previously the calculated and measured
systemic venous-arterial CO2 content difference (mea-
sured as systemic arterial-venous O2 content difference
multiplied by RQ obtained from indirect calorimetry
[51]). The coefficient of correlation was 0.772 (p<0.001).
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The mean of the calculated venous-arterial CO2 content
difference was 3.52±0.95, and the mean of the measured
venous-arterial CO2 content difference was 3.97±1.06.
The difference between the means was therefore
0.44±0.69, and the 95% confidence interval was −0.63 to
−0.25, and significantly different from zero (p<0.001).
Although the standard deviation of the means was similar
to the one reported by Giovannini et al. (0.69 vs. 0.59),
we found a bias which was not reported in their investiga-
tion. Since we were looking at changes in venous-arterial
CO2 content difference rather than absolute values, this
bias is unlikely to confound the results.
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